Latest Research
All publications from the Cancer3.AI database, newest first.
Aberrant expression of the testis kinase TSSK6activates FAK-STAT3 signaling to promote tumorigenic growth.
Delgado M, et al
Researchers investigated how a normally germ-cell-restricted protein called Testis-Specific Serine Kinase 6 (TSSK6) drives cancer progression when it is abnormally switched on in colorectal cancer cells. The study found that aberrant TSSK6 expression activates focal adhesion kinase (FAK), which in turn phosphorylates and activates the transcription factor STAT3, unleashing gene programs that remodel the extracellular matrix and promote cell movement and adhesion. These STAT3-driven transcriptional changes enable cancer cells to survive without anchorage to surrounding tissue—a process called anoikis resistance—and to invade neighboring tissues, both critical steps in cancer spread and metastasis. Blocking the FAK-STAT3 signaling axis shut down these aggressive behaviors in laboratory models, including spheroid invasion assays. These findings identify the FAK-STAT3 pathway as a potential therapeutic target in colorectal cancers that aberrantly express TSSK6, opening avenues for new treatment strategies in a disease where metastatic spread remains a major clinical challenge.
bioRxiv : the preprint server for biology
Source →Multimodal spatial alignment and morphology mapping with MOSAICField.
Liu X, et al
Researchers have developed MOSAICField, a computational framework that integrates data from multiple cutting-edge spatial biology technologies to build accurate three-dimensional models of tumors and healthy tissues. Modern cancer research relies on dozens of technologies that each measure different molecular features—such as gene activity, proteins, or epigenetic marks—at precise locations within a tissue slice, but combining these datasets has been extremely difficult due to differences in resolution and tissue orientation. MOSAICField uses a deep neural network to calculate two types of spatial alignment: a physical alignment that reconstructs a continuous 3D tissue model, and a morphological alignment that tracks anatomical structures such as ducts or blood vessels across slices cut at different angles. When tested on a prostate cancer sample from the Human Tumor Atlas Network comprising more than a dozen tissue slices with multimodal data, MOSAICField successfully reconstructed the 3D tumor architecture and mapped the prostatic ductal system with greater accuracy than existing tools. This advance could help researchers and clinicians better understand how cancer develops across the full three-dimensional structure of a tumor, ultimately improving the interpretation of complex multi-omic datasets used in precision oncology.
bioRxiv : the preprint server for biology
Source →Treatment modality-specific survival of small cell neuroendocrine carcinoma of the uterine cervix with T1b3-2b classifications.
Kobayashi M, et al
A new retrospective study analyzed survival outcomes across different treatment approaches for a rare and aggressive cancer called small cell neuroendocrine carcinoma of the uterine cervix in patients with bulky, locally advanced disease. Researchers examined data from 197 patients in the U.S. National Cancer Database between 2006 and 2022, comparing outcomes for those who received radiation plus chemotherapy alone versus those who also underwent surgical removal of the uterus (hysterectomy). The key finding was that patients who had a primary hysterectomy followed by postoperative radiation and chemotherapy achieved a five-year overall survival rate of 68.9%, compared to only 46.9% for those treated with radiation and chemotherapy without surgery. This survival benefit held even among patients whose cancer had spread to lymph nodes, suggesting that surgery may play an important role in comprehensive treatment of this disease. The authors caution that these are hypothesis-generating results and that the surgical approach may be especially relevant in settings where high-quality radiotherapy is not readily available. Clinicians treating this rare cervical cancer subtype may consider incorporating hysterectomy into multimodal treatment plans for carefully selected patients.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Source →Ruxolitinib reverses systemic vasculitis driven by JAK2 V617F-mutated essential thrombocythemia: a case report.
Ashida Y, et al
Researchers from Frontiers in Immunology report a rare case linking essential thrombocythemia (ET), a blood disorder caused by a JAK2 V617F genetic mutation, with systemic vasculitis, an inflammatory condition affecting blood vessels. A 60-year-old male patient with this mutation suffered repeated heart attacks and coronary stent blockages before surgeons discovered during a bypass operation that his blood vessels were inflamed. Following the vasculitis diagnosis, the patient was treated with a combination of hydroxycarbamide and ruxolitinib, a targeted JAK inhibitor drug, which successfully reduced platelet counts and resolved the vascular inflammation. No further cardiovascular events occurred after treatment was initiated, suggesting meaningful clinical benefit. This case highlights that vasculitis can be an underrecognized complication of JAK2-mutated ET and that ruxolitinib may offer an effective therapeutic option for managing this dangerous combination of conditions.
Frontiers in immunology
Source →Parathyroid Carcinoma Mimicking Thyroid Hyalinizing Trabecular Tumor: A Case Report and Review of Atypical Presentations of Parathyroid Carcinoma.
Loreto-Palacio P, et al
Researchers report a rare case of parathyroid carcinoma — a malignant tumor of the parathyroid glands — that closely resembled a benign thyroid tumor known as hyalinizing trabecular tumor, creating a significant diagnostic challenge. The tumor displayed an unusual trabecular (column-like) growth pattern, a hyalinized (glassy) connective tissue stroma, and distinctive nuclear features such as grooves and pseudoinclusions, all of which are hallmarks typically associated with thyroid rather than parathyroid neoplasms. This case highlights how parathyroid carcinoma can present in highly atypical ways that fall outside classic diagnostic criteria, increasing the risk of misclassification as a less dangerous thyroid lesion. Accurate diagnosis is critical because parathyroid carcinoma requires a different and more aggressive clinical management strategy than benign thyroid tumors. Pathologists and clinicians must be aware of this rare morphological pattern to ensure patients receive the correct diagnosis and appropriate treatment in a timely manner.
International journal of surgical pathology
Source →